News | November 02, 2022
Advent International launches Cohance Lifesciences
API platform to comprise of RA Chem Pharma, ZCL Chemicals and Avra Laboratories
API platform to comprise of RA Chem Pharma, ZCL Chemicals and Avra Laboratories
CEPI will provide up to US$40 million in initial funding to support the development of mRNA-vaccine candidates against Lassa Fever virus
Juan Andres Appointed to President, Strategic Partnerships and Enterprise Expansion
The booster vaccination trial is still ongoing and further data will provide more information around safety and efficacy.
This newly launched institute will be the centre of excellence in the treatment of all cancers under a single roof.
Philips Foundation and RAD-AID International leverage Philips’ expertise in mobile ultrasound services to improve access to virtual care in hard-to-reach areas
Under the terms of the agreement, Lonza can now provide its customers with seamless access to Touchlight’s enzymatic DNA technology
COVID-19 Vaccine (DS-5670) in Unvaccinated Individuals in Japan
Complaints to be filed in both United States and Germany alleging that Pfizer and BioNTech's COVID-19 vaccine Comirnaty unlawfully infringes patents Moderna filed between 2010 and 2016
Pending authorization, Moderna ready to ship bivalent booster mRNA-1273.222 in September
Subscribe To Our Newsletter & Stay Updated
